焼津市立総合病院 副病院長兼患者支援センター長
日本外科学会 外科専門医・指導医 日本消化器外科学会 消化器外科専門医・消化器外科指導医・消化器がん外科治療認定医 日本大腸肛門病学会 大腸肛門病専門医・大腸肛門病指導医・評議員 日本消化器内視鏡学会 消化器内視鏡専門医・消化器内視鏡指導医 日本がん治療認定医機構 がん治療認定医 日本内視鏡外科学会 技術認定取得者(消化器・一般外科領域)・ロボット支援手術認定プロクター(消化器・一般外科) 日本ロボット外科学会 国内B級認定ロボット手術専門医 日本臨床外科学会 評議員
続きを読む
日本外科学会 | 外科専門医・指導医 |
---|---|
日本消化器外科学会 | 消化器外科専門医・消化器外科指導医・消化器がん外科治療認定医 |
日本大腸肛門病学会 | 大腸肛門病専門医・大腸肛門病指導医・評議員 |
日本消化器内視鏡学会 | 消化器内視鏡専門医・消化器内視鏡指導医 |
日本がん治療認定医機構 | がん治療認定医 |
日本内視鏡外科学会 | 技術認定取得者(消化器・一般外科領域)・ロボット支援手術認定プロクター(消化器・一般外科) |
日本ロボット外科学会 | 国内B級認定ロボット手術専門医 |
日本臨床外科学会 | 評議員 |
焼津市立総合病院
1993年
東京大学医学部医学科
卒業
2002年
東京大学大学院医学系研究科外科学専攻博士過程修了 医学博士取得
修了・医学博士取得
2005年
東京大学医学部附属病院 大腸肛門外科
助教
2014年
キッコーマン総合病院
外科部長
2015年
東京大学医学部附属病院 大腸肛門外科
特任講師
2015年
埼玉県立がんセンター 消化器外科
副部長
2023年
焼津市立総合病院
副院長
A case of resected retroperitoneal metachronous solitary metastasis from caecal cancer. Ann R Coll Surg Engl 2020,102:e198-e201.
Kazama S, Anzai H, Matsuzawa N, Nishimura Y, Ishii H, Nishizawa Y, Kanda H, Kawashima Y, Sakamoto H
Immunohistochemical Expression of CD133 and LGR5 in Ulcerative Colitis-associated Colorectal Cancer and Dysplasia. In Vivo 2019, 33(4):1279-1284.
Kazama S, Kishikawa J, Tanaka T, Hata K, Kawai K, Nozawa H, Ishihara S
Results of a 36-year surveillance program for ulcerative colitis-associated neoplasia in the Japanese population. Dig Endosc 2018, 30(2):236-244.
Kishikawa J, Hata K, Kazama S, Anzai H, Shinagawa T, Murono K, Kaneko M, Sasaki K, Yasuda K, Otani K et al
Expression of the stem cell marker CD133 is related to tumor development in colorectal carcinogenesis. Asian J Surg 2018, 41(3):274-278.
Kazama S, Kishikawa J, Kiyomatsu T, Kawai K, Nozawa H, Ishihara S, Watanabe T
The short-term outcomes of robotic sphincter-preserving surgery for rectal cancer: comparison with open and laparoscopic surgery using a propensity score analysis. Int J Colorectal Dis 2018, 33(8):1047-1055.
Ishihara S, Kiyomatsu T, Kawai K, Tanaka T, Hata K, Kazama S, Sunami E, Nozawa H, Watanabe T.
Prognostic impact of doublecortin-like kinase 1 expression in locally advanced rectal cancer treated with preoperative chemoradiotherapy. Apmis 2018, 126(6):486-493.
Harada Y, Kazama S, Morikawa T, Emoto S, Murono K, Kaneko M, Sasaki K, Otani K, Nishikawa T, Tanaka T et al
Leucine-rich repeat-containing G protein-coupled receptor 5 and CD133 expression is associated with tumor progression and resistance to preoperative chemoradiotherapy in low rectal cancer. Oncol Lett 2017, 14(6):7791-7798.
Harada Y, Kazama S, Morikawa T, Murono K, Yasuda K, Otani K, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K et al
Perianal and Vulvar Extramammary Paget Disease: A Report of Six Cases and Mapping Biopsy of the Anal Canal. Ann Dermatol 2016, 28(5):624-628.
Nagai Y, Kazama S, Yamada D, Miyagawa T, Murono K, Yasuda K, Nishikawa T, Tanaka T, Kiyomatsu T, Hata K et al
CD133 Expression at the Metastatic Site Predicts Patients' Outcome in Colorectal Cancer with Synchronous Liver Metastasis. Ann Surg Oncol 2016, 23(6):1916-1923.
Kishikawa J, Kazama S, Oba K, Hasegawa K, Anzai H, Harada Y, Abe H, Matsusaka K, Hongo K, Oba M et al
Surveillance colonoscopy for colitis-associated dysplasia and cancer in ulcerative colitis patients. Dig Endosc 2016, 28(3):260-265.
Hata K, Kishikawa J, Anzai H, Shinagawa T, Kazama S, Ishii H, Nozawa H, Kawai K, Kiyomatsu T, Tanaka J et al
Prognostic Impact of Histologic Type in Curatively Resected Stage IV Colorectal Cancer: A Japanese Multicenter Retrospective Study. Ann Surg Oncol 2015, 22 Suppl 3(3):S621-629.
Shibata J, Kawai K, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Hata K, Nozawa H, Kazama S, Yamaguchi H et al
The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer. Int J Colorectal Dis 2015, 30(9):1165-1171.
Ozawa T, Ishihara S, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Hata K, Kawai K, Nozawa H, Kazama S et al
Impact of a lymphocyte to monocyte ratio in stage IV colorectal cancer. J Surg Res 2015, 199(2):386-392.
Ozawa T, Ishihara S, Kawai K, Kazama S, Yamaguchi H, Sunami E, Kitayama J, Watanabe T.
Predictors and outcome of complete removal of colorectal cancer with synchronous lung metastases. Mol Clin Oncol 2015, 3(5):1041-1047.
Nozawa H, Tanaka J, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K, Hata K, Kazama S, Yamaguchi H, Ishihara S et al
Large Colorectal Carcinoma Is Predictive of Recurrence After Adjuvant Chemotherapy Using Oxaliplatin. Anticancer Res 2015, 35(9):5073-5078.
Nozawa H, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Hata K, Kazama S, Yamaguchi H, Ishihara S et al
Detection of carcinoembryonic antigen mRNA in peritoneal lavage by the transcription-reverse transcription concerted method indicates poor prognosis in patients with stage II and III colon cancer. Surgery 2015, 157(2):322-330.
Murono K, Kazama S, Yamaguchi H, Kawai K, Ishihara S, Sunami E, Kitayama J, Satoh Y, Kurihara M, Yatomi Y et al
Anatomy of the inferior mesenteric artery evaluated using 3-dimensional CT angiography. Dis Colon Rectum 2015, 58(2):214-219.
Murono K, Kawai K, Kazama S, Ishihara S, Yamaguchi H, Sunami E, Kitayama J, Watanabe T
Phospholipase A2 Group III and Group X Have Opposing Associations with Prognosis in Colorectal Cancer. Anticancer Res 2015, 35(5):2983-2990.
Kazama S, Kitayama J, Hiyoshi M, Taketomi Y, Murakami M, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K et al
CD133 Expression in Lymph Node Metastases Is Associated with Tumor Aggressiveness During Lymph Node Metastasis in Colorectal Cancer. Anticancer Res 2015, 35(12):6599-6605.
Kazama S, Kishikawa J, Yasuda K, Otani K, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Hata K et al
Benefit of primary tumor resection in stage IV colorectal cancer with unresectable metastasis: a multicenter retrospective study using a propensity score analysis. Int J Colorectal Dis 2015, 30(6):807-812.
Ishihara S, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Hata K, Nozawa H, Kazama S, Yamaguchi H et al
Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study. World J Surg Oncol 2015, 13(7):7.
Hongo K, Kazama S, Tsuno NH, Ishihara S, Sunami E, Kitayama J, Watanabe T
Chemoradiation provides a physiological selective pressure that increases the expansion of aberrant TP53 tumor variants in residual rectal cancerous regions. Oncotarget 2014, 5(20):9641-9649.
Sakai K, Kazama S, Nagai Y, Murono K, Tanaka T, Ishihara S, Sunami E, Tomida S, Nishio K, Watanabe T
Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer. Ann Surg Oncol 2014, 21(8):2650-2658.
Ozawa T, Kazama S, Akiyoshi T, Murono K, Yoneyama S, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Nozawa H et al
Perianal adenocarcinoma associated with anal fistula: a report of 11 cases in a single institution focusing on treatment and literature review. Hepatogastroenterology 2013, 60(124):720-726.
Hongo K, Kazama S, Sunami E, Kitayama J, Watanabe T
Six cases of primary colorectal cancer after living-donor liver transplantation: a single-institution experience in Japan. Jpn J Clin Oncol 2012, 42(7):586-590.
Kazama S, Hongo K, Sunami E, Sugawara Y, Kokudo N, Kitayama J
Immunohistochemical detection of autotaxin (ATX)/lysophospholipase D (lysoPLD) in submucosal invasive colorectal cancer. J Gastrointest Cancer 2011, 42(4):204-211.
Kazama S, Kitayama J, Aoki J, Mori K, Nagawa H
Vascular endothelial growth factor-C (VEGF-C) is a more specific risk factor for lymph node metastasis than VEGF-D in submucosal colorectal cancer. Hepatogastroenterology 2007, 54(73):71-76.
Kazama S, Watanabe T, Kanazawa T, Hatano K, Nagawa H
Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. Br J Cancer 2006, 94(2):293-298.
Kazama S, Watanabe T, Ajioka Y, Kanazawa T, Nagawa H
Expression pattern of vascular endothelial growth factor-C in human colorectal normal mucosa and neoplastic mucosa. Hepatogastroenterology 2004, 51(56):391-395.
Kazama S, Kitayama J, Watanabe T, Nagawa H
Not infrequent K-ras mutations in depressed-type early colorectal carcinomas larger than 10 mm. Jpn J Cancer Res 2002, 93(2):178-183.
Kazama S, Ajioka Y, Watanabe H, Watanabe T, Nagawa H
Histogenesis and morphogenesis of depressed-type early colorectal carcinoma. Pathol Int 2002, 52(2):119-125.
Kazama S, Ajioka Y, Watanabe H, Watanabe T, Nagawa H
本ページにおける情報は、医師本人の申告に基づいて掲載しております。内容については弊社においても可能な限り配慮しておりますが、最新の情報については公開情報等をご確認いただき、またご自身でお問い合わせいただきますようお願いします。
なお、弊社はいかなる場合にも、掲載された情報の誤り、不正確等にもとづく損害に対して責任を負わないものとします。